[go: up one dir, main page]

WO2000078954A3 - Proteines de regulateur de transcription humaines - Google Patents

Proteines de regulateur de transcription humaines Download PDF

Info

Publication number
WO2000078954A3
WO2000078954A3 PCT/US2000/016766 US0016766W WO0078954A3 WO 2000078954 A3 WO2000078954 A3 WO 2000078954A3 US 0016766 W US0016766 W US 0016766W WO 0078954 A3 WO0078954 A3 WO 0078954A3
Authority
WO
WIPO (PCT)
Prior art keywords
transcriptional regulator
regulator proteins
txreg
human transcriptional
provides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/016766
Other languages
English (en)
Other versions
WO2000078954A2 (fr
Inventor
Preeti Lal
Henry Yue
Y Tom Tang
Mariah R Baughn
Yalda Azimzai
Bao Tran
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc filed Critical Incyte Genomics Inc
Priority to AU56230/00A priority Critical patent/AU5623000A/en
Priority to EP00941530A priority patent/EP1190050A2/fr
Priority to CA002375414A priority patent/CA2375414A1/fr
Priority to JP2001505696A priority patent/JP2003517290A/ja
Publication of WO2000078954A2 publication Critical patent/WO2000078954A2/fr
Publication of WO2000078954A3 publication Critical patent/WO2000078954A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

L'invention concerne des protéines de régulateur de transcription humaines (TXREG) et des polynucléotides qui identifient et codent pour TXREG. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. L'invention concerne également des méthodes permettant de diagnostiquer, de traiter ou de prévenir des affections associées à l'expression de TXREG.
PCT/US2000/016766 1999-06-18 2000-06-15 Proteines de regulateur de transcription humaines Ceased WO2000078954A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU56230/00A AU5623000A (en) 1999-06-18 2000-06-15 Human transcriptional regulator proteins
EP00941530A EP1190050A2 (fr) 1999-06-18 2000-06-15 Proteines de regulateur de transcription humaines
CA002375414A CA2375414A1 (fr) 1999-06-18 2000-06-15 Proteines de regulateur de transcription humaines
JP2001505696A JP2003517290A (ja) 1999-06-18 2000-06-15 ヒト転写調節タンパク質

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14010999P 1999-06-18 1999-06-18
US60/140,109 1999-06-18

Publications (2)

Publication Number Publication Date
WO2000078954A2 WO2000078954A2 (fr) 2000-12-28
WO2000078954A3 true WO2000078954A3 (fr) 2001-08-23

Family

ID=22489799

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/016766 Ceased WO2000078954A2 (fr) 1999-06-18 2000-06-15 Proteines de regulateur de transcription humaines

Country Status (5)

Country Link
EP (1) EP1190050A2 (fr)
JP (1) JP2003517290A (fr)
AU (1) AU5623000A (fr)
CA (1) CA2375414A1 (fr)
WO (1) WO2000078954A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001027270A1 (fr) * 1999-10-08 2001-04-19 Chugai Seiyaku Kabushiki Kaisha Gene ys68 associe a l'hematopoiese precoce
JP4112976B2 (ja) * 2000-11-09 2008-07-02 株式会社Ｊｉｍｒｏ Ｐｃａ２５０１遺伝子
US20040072997A1 (en) * 2000-12-20 2004-04-15 Alsobrook John P. Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US20030219739A1 (en) * 2001-01-30 2003-11-27 Glass David J. Novel nucleic acid and polypeptide molecules
JP3810731B2 (ja) 2002-11-29 2006-08-16 独立行政法人科学技術振興機構 哺乳動物のＴｏｌｌ様受容体３に結合する新規アダプタータンパク質およびその遺伝子
WO2004078112A2 (fr) * 2003-03-07 2004-09-16 Asahi Kasei Pharma Corporation Gene induisant l'apoptose
EP2163624A1 (fr) * 2004-09-24 2010-03-17 Oncotherapy Science, Inc. Procédé de diagnostic de cancers des poumons à cellules non petites par une activité de synthase tRNA-dihydrouridine d'URLC8

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726288A (en) * 1989-11-13 1998-03-10 Massachusetts Institute Of Technology Localization and characterization of the Wilms' tumor gene
US5861495A (en) * 1997-01-21 1999-01-19 Incyte Pharmaceuticals, Inc. Human zinc binding proteins

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5726288A (en) * 1989-11-13 1998-03-10 Massachusetts Institute Of Technology Localization and characterization of the Wilms' tumor gene
US5861495A (en) * 1997-01-21 1999-01-19 Incyte Pharmaceuticals, Inc. Human zinc binding proteins

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL EBI; 14 August 1996 (1996-08-14), MARRA ET AL.: "The WashU-HHMI Mouse EST project", XP002152509 *
DATABASE EMBL EBI; 17 March 1999 (1999-03-17), MARRA ET AL.: "The WashU-NCI mouse EST project", XP002152510 *
DATABASE EMBL EBI; 19 January 1997 (1997-01-19), HILLIER ET AL.: "Generation and analysis of 280,000 human expressed sequence tags", XP002152511 *
RAZDAN ET AL.: "Molecular cloning of a novel platelet protein showing homology to the angiotensin II receptor C-terminal domain", THE JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 271, no. 4, 26 January 1996 (1996-01-26), pages 2221 - 2224, XP002152508 *
REUTER S ET AL: "APM-1, A NOVEL HUMAN GENE, IDENTIFIED BY ABERRANT CO-TRANSCRIPTION WITH PAPILLOMAVIRUS ONCOGENES IN A CERVICAL CARCINOMA CELL LINE, ENCODES A BTB/POZ-ZINC FINGER PROTEIN WITH GROWTH INHIBITORY ACTIVITY", EMBO JOURNAL,GB,OXFORD UNIVERSITY PRESS, SURREY, vol. 17, no. 1, 1 January 1998 (1998-01-01), pages 215 - 222, XP000867721, ISSN: 0261-4189 *

Also Published As

Publication number Publication date
JP2003517290A (ja) 2003-05-27
CA2375414A1 (fr) 2000-12-28
AU5623000A (en) 2001-01-09
WO2000078954A2 (fr) 2000-12-28
EP1190050A2 (fr) 2002-03-27

Similar Documents

Publication Publication Date Title
WO2001012662A3 (fr) Proteines associees a la membrane
WO1999061471A3 (fr) Proteines transmembranaires humaines
WO2001007628A3 (fr) Synthetases humaines
WO2000015793A3 (fr) Proteines gpcr humaines
WO2000018922A8 (fr) Proteines humaines associees a des glucides
WO2000034477A3 (fr) Proteines associees a des neurones
WO1999057144A3 (fr) Molecules de regulateur de transcription humaine
WO1999058692A3 (fr) Proteines associees a l'apoptose humaine
WO2000009709A3 (fr) Proteases et proteines associees
WO2000026245A3 (fr) Proteines de transport membranaire
WO2000017355A3 (fr) Proteines humaines associees au cytosquelette
WO2001007612A3 (fr) Recepteurs et proteines associees
WO2001005970A3 (fr) Proteines associees de liaison gtp
WO2000014251A3 (fr) Transferases humaines
WO2000052151A3 (fr) Proteines de secretion humaines
WO2000078953A3 (fr) Proteines de transport humaines
WO2000056891A3 (fr) Proteines transmembranaires humaines
WO2001044448A3 (fr) Proteines d'oxydoreductase humaines
WO2000055332A3 (fr) Regulateur de la phosphorylation intracellulaire
WO1999061614A3 (fr) Proteines socs humaines
WO2000031263A3 (fr) Proteines associees a la gtpase
WO2000042201A3 (fr) Peptidases humaines
WO2000028045A3 (fr) Hydrolases humaines
WO2000078954A3 (fr) Proteines de regulateur de transcription humaines
WO2000065054A3 (fr) Proteines humaines associees aux membranes

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2375414

Country of ref document: CA

Ref country code: CA

Ref document number: 2375414

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 505696

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 2000941530

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000941530

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 2000941530

Country of ref document: EP